Ragosa Mark Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
12
Insider Sells Sum
$5.38M

Insider Activity of Ragosa Mark

According to the SEC Form 4 filings, Ragosa Mark, being in a position of

  1. CHIEF FINANCIAL OFFICER at Kiniksa Pharmaceuticals International, plc,
    оver the last 12 months, has bought 0 shares, and sold 166091 share for $8.94M,
    over all time since 2024-01-03, has bought 0 shares, and sold 427138 shares for $15.48M.

Biography of Ragosa Mark

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $8,943,2476100

Comparison of Insiders on Amount of Buys and Sells

2026-11-02SaleKiniksa Pharmaceuticals International, plc
KNSA
CHIEF FINANCIAL OFFICER
36,783
0.0477%
$92.16$3.39M+1.22%
2026-03-09SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF FINANCIAL OFFICER
36,722
0.0492%
$45.92$1.69M+34.09%
2026-02-09SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF FINANCIAL OFFICER
17,845
0.0238%
$43.28$772,254+33.48%
2026-01-08SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF FINANCIAL OFFICER
12,000
0.0164%
$41.89$502,680+36.15%
2025-12-08SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF FINANCIAL OFFICER
42,841
0.0584%
$41.49$1.78M+28.38%
2025-11-12SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF FINANCIAL OFFICER
19,900
0.029%
$40.94$814,706+26.2%
2025-10-28SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF FINANCIAL OFFICER
100
0.0001%
$41.00$4,100+23.51%
2025-08-04SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF FINANCIAL OFFICER
18,889
0.0262%
$32.89$621,259+31.08%
2025-06-03SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF FINANCIAL OFFICER
18,299
0.0248%
$28.80$527,011+40.85%
2025-05-01SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF FINANCIAL OFFICER
25,141
0.0345%
$27.80$698,920+40.05%
2025-04-30SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF FINANCIAL OFFICER
21,254
0.0291%
$26.95$572,795+43.97%
2025-04-29SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF FINANCIAL OFFICER
42,000
0.057%
$25.61$1.08M+49.81%
2025-03-20SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF FINANCIAL OFFICER
15,944
0.0213%
$23.11$368,466+53.25%
2025-03-19SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF FINANCIAL OFFICER
8,879
0.0122%
$23.10$205,105+57.41%
2025-03-12SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF FINANCIAL OFFICER
36,372
0.0495%
$22.25$809,277+58.98%
2024-12-09SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF FINANCIAL OFFICER
18,860
0.0261%
$21.38$403,227+30.09%
2024-12-06SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF FINANCIAL OFFICER
8,969
0.0123%
$21.27$190,771+28.64%
2024-12-05SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF FINANCIAL OFFICER
1,123
0.0016%
$21.25$23,864+31.84%
2024-12-03SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF FINANCIAL OFFICER
8,969
0.0128%
$21.45$192,385+30.09%
2024-07-23SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF FINANCIAL OFFICER
24,248
0.0323%
$24.79$601,108-8.77%
Total: 21
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.